AngioDynamics' Med Tech growth and reimbursement gains strengthen its outlook, but tariffs, rising c

AngioDynamics' fiscal 2027 outlook hinges on Med Tech growth offsetting flat device sales as tariffs

AngioDynamics' 33.5% three-month rally rests on Med Tech growth, but valuation, tariffs and negative

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medi

AngioDynamics develops tools for minimally invasive procedures across blood flow, blocked arteries,

HC Wainwright & Co. analyst Yi Chen maintains AngioDynamics (NASDAQ:ANGO) with a Buy and rais

ANGO's Q4 FY26 revenues rise 8% as Med Tech surges, while its adjusted loss beats estimates and FY27

Canaccord Genuity analyst John Young maintains AngioDynamics (NASDAQ:ANGO) with a Buy and raises

AngioDynamics, Inc. (ANGO) Q4 2026 Earnings Call Transcript

AngioDynamics NASDAQ: ANGO reported higher fiscal fourth-quarter and full-year revenue, driven by co

AngioDynamics (NASDAQ:ANGO) released fourth-quarter financial results and hosted an earnings call on

AngioDynamics (ANGO) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Es

Companies Reporting Before The Bell • Grupo Aeroportuario del (NYSE:PAC) is likely to report quarter

AngioDynamics (NASDAQ:ANGO) is looking for FY2027 Adj EPS of $(0.29)-$(0.24) vs $(0.16) analyst esti

AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.07) per share which beat the analyst co

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medi

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focu

ANGO's NanoKnife growth, strong Med Tech momentum and solid Q3 results support holding the stock des

AngioDynamics' FDA IDE approval for RELIEF advances NanoKnife IRE study as a potential minimally inv

AngioDynamics, Inc. (NASDAQ:ANGO), a medical technology company focused on restoring healthy blood f

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focu

AngioDynamics, Inc. (ANGO) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 P

U.S. stock futures surged on Wed. as Nasdaq futures rose over 7%, driven by AI. Marvell's stock

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focu

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medi

The mean of analysts' price targets for AngioDynamics (ANGO) points to a 50.5% upside in the stock.

ANGO gains momentum as NanoKnife adoption, strong Med Tech growth and positive clinical trends suppo

Pivotal U.S. Data Show Sustained Oncologic Control and Safety Profile at 24 monthsResults Presented

Canaccord Genuity analyst John Young maintains AngioDynamics (NASDAQ:ANGO) with a Buy and lowers

AngioDynamics (NASDAQ:ANGO) raises FY2026 Adj EPS guidance from $(0.33)-$(0.23) to $(0.30)-$(0.23) v

AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.07) per share which beat the analyst co

Stocks end higher, Fear & Greed Index eases, Trump suggests quick military withdrawal from Iran,

U.S. stock futures trading lower, Acuity and Visionary Holdings report strong earnings, Lindsay Cor

Growing Clinical Evidence and Physician Adoption Broaden NanoKnife IRE Technology as Treatment Optio

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 0.2% on

U.S. stock futures were fluctuating on Thursday following Wednesday's record advances. Futures o

CNN Business Fear & Greed Index at 52.3, remaining in Neutral zone. Stocks close higher despite

  During Tuesday's trading, 188 companies set new 52-week lows.

  On Wednesday, 345 companies set new 52-week lows.